Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder
- PMID: 25384461
- DOI: 10.1002/mds.26055
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder
Abstract
Hyperechogenicity of the substantia nigra visualized by transcranial sonography occurs in most Parkinson's disease (PD) patients. Idiopathic rapid eye movement (REM) sleep behavior disorder (IRBD) subjects eventually develop PD and other synucleinopathies. This study was undertaken to evaluate whether in IRBD, transcranial sonography identifies subjects who convert to PD and other synucleinopathies, and whether substantia nigra echogenic size changes with time. It was a prospective study in which 55 IRBD patients underwent transcranial sonography at baseline and were invited to follow-up after 5 years. Patients were assessed by the same experienced sonographer who was blinded to clinical data and baseline transcranial sonography results, and used the same equipment and adjustments. Twenty-one (38.2%) subjects were diagnosed with a synucleinopathy (PD in 11, dementia with Lewy bodies in nine, and multiple system atrophy in one). Sensitivity of baseline substantia nigra hyperechogenicity for the development of a synucleinopathy was 42.1%, specificity 67.7%, positive predictive value 44.4%, negative predictive value 65.6%, and relative risk 1.29. No differences were detected between the first and second examination in mean size of the substantia nigra (0.20 ± 0.09 cm(2) vs. 0.19 ± 0.07 cm(2) ; P = 0.777) and in percentage of patients with substantia nigra hyperechogenicity (33.3% vs. 42.8%, P = 0.125). Transcranial sonography of the substantia nigra alone is not a useful tool to identify IRBD subjects at risk for the development of PD or a synucleinopathy after 5 years of follow-up. In IRBD, transcranial sonography cannot be used to monitor the degenerative process in the substantia nigra, because echogenicity size remains stable over time.
Keywords: Parkinson's disease; REM sleep behavior disorder; follow-up; substantia nigra echogenicity; transcranial sonography.
© 2014 International Parkinson and Movement Disorder Society.
Similar articles
-
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Lancet Neurol. 2010. PMID: 20846908
-
Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy.Psychiatry Clin Neurosci. 2017 Apr;71(4):238-246. doi: 10.1111/pcn.12483. Epub 2017 Jan 9. Psychiatry Clin Neurosci. 2017. PMID: 27898200
-
Comparative study of the substantia nigra echogenicity and 123I-Ioflupane SPECT in patients with synucleinopathies with and without REM sleep behavior disorder.Sleep Med. 2020 Jun;70:116-123. doi: 10.1016/j.sleep.2020.02.012. Epub 2020 Feb 28. Sleep Med. 2020. PMID: 32403038
-
[Transcranial sonography of substantia nigra in patients with Parkinson's disease].Rinsho Shinkeigaku. 2013;53(11):981-2. doi: 10.5692/clinicalneurol.53.981. Rinsho Shinkeigaku. 2013. PMID: 24291852 Review. Japanese.
-
Transcranial sonography in Parkinson's disease.Einstein (Sao Paulo). 2012 Apr-Jun;10(2):242-6. doi: 10.1590/s1679-45082012000200022. Einstein (Sao Paulo). 2012. PMID: 23052464 Review. English, Portuguese.
Cited by
-
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?J Neural Transm (Vienna). 2018 Oct;125(10):1417-1432. doi: 10.1007/s00702-018-1910-4. Epub 2018 Aug 25. J Neural Transm (Vienna). 2018. PMID: 30145631 Free PMC article. Review.
-
Premotor Diagnosis of Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3. Neurosci Bull. 2017. PMID: 28776303 Free PMC article. Review.
-
Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.Nat Rev Neurol. 2018 Jan;14(1):40-55. doi: 10.1038/nrneurol.2017.157. Epub 2017 Nov 24. Nat Rev Neurol. 2018. PMID: 29170501 Review.
-
Baseline characteristics of the North American prodromal Synucleinopathy cohort.Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8. Ann Clin Transl Neurol. 2023. PMID: 36751940 Free PMC article. Clinical Trial.
-
Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.J Parkinsons Dis. 2022;12(4):1115-1123. doi: 10.3233/JPD-213012. J Parkinsons Dis. 2022. PMID: 35180133 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical